EN | RU
EN | RU

Help Support

Back

Vitamin D supplementation improves severity of depression

General comorbid situation General comorbid situation
General comorbid situation General comorbid situation

What's new?

In patients with depression, the use of vitamin D for eight weeks leads to a reduction in Beck Depression Inventory-II (BDI-II) scores.

An eight-week supplementation with vitamin D in adults with mild to moderate depression led to a considerable rise in serum 25(OH)D concentrations, which was followed by a reduction in the severity of the patient's depression, according to a double-blind, randomized clinical trial. Mina Kaviani et al. sought to assess the impact of supplementing vitamin D on the concentration of serum 25(OH)D, the severity of depression, and some pro-inflammatory biomarkers in patients with depression.

Overall, 56 people (aged 18-60 years) with mild to moderate depression were randomized to control (placebo) and intervention (50,000 IU cholecalciferol 2 weeks-1) groups. Initial and final measurements included those of depression severity (Beck Depression Inventory-II [BDI-II]), high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-1β, IL-6, intact parathyroid hormone (iPTH), and serum 25(OH)D.

At the end point, only the intervention group showed clinically meaningful alterations contrasted to the controls, encompassing elevated 25(OH)D concentration (+ 40.83 ± 28.57 vs. + 5.14 ± 23.44 nmol L-1) and declined severity of depression (-11.75 ± 6.40 vs. -3.61 ± 10.40). There were no discernible variations in serum IL-1β, IL-6, or hs-CRP concentrations between or within groups.

Patients suffering from mild to moderate depression who received vitamin D for eight weeks (50,000 IU 2 weeks-1) had a substantial drop in their BDI-II scores. But, this impact was unrelated to the serum concentrations of the investigated inflammatory biomarkers.

Source:

BMC Psychiatry

Article:

Effects of vitamin D supplementation on depression and some selected pro-inflammatory biomarkers: a double-blind randomized clinical trial

Authors:

Mina Kaviani et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: